However, the sensitivity of IL-6 is too low to estimate disease activity in non-progressive neuro-Behçet’s disease or MS [32–34], indicating that IL-6 is of limited utility as a biomarker of neuroinflammation. The gene discussed is IL6; the disease is myeloid sarcoma.